The Strand Displacement Amplification Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Application (Tuberculosis, Hepatitis, Malaria, Influenza, Cancer, Others), By End-User (Hospitals, Diagnostic laboratories, Others).
In 2024, the market for strand displacement amplification (SDA) technology continues to play a crucial role in molecular diagnostics, offering a sensitive and rapid method for nucleic acid amplification in various applications such as pathogen detection, genetic testing, and infectious disease monitoring. Strand displacement amplification utilizes isothermal enzymatic reactions to amplify specific DNA or RNA sequences, enabling the detection and quantification of target nucleic acids with high sensitivity and specificity. With advancements in primer design, enzyme engineering, and detection strategies, SDA technology offers robust performance, multiplexing capabilities, and compatibility with point-of-care testing devices. Moreover, the market is influenced by trends such as the integration of SDA assays into diagnostic platforms for decentralized testing, the development of portable and user-friendly SDA kits for resource-limited settings, and the expansion of SDA applications to emerging infectious diseases and antimicrobial resistance surveillance. Additionally, ongoing research focuses on optimizing reaction conditions, improving assay speed and throughput, and expanding the repertoire of molecular targets for SDA-based diagnostics, reflecting the continuous innovation and evolution of SDA technology in meeting the diverse needs of clinical laboratories, public health agencies, and research institutions.
The market trend of Strand Displacement Amplification (SDA) is witnessing a significant uptake due to the growing adoption of Point-of-Care Testing (POCT). POCT offers rapid and convenient diagnostic solutions outside of traditional laboratory settings, enabling quicker decision-making in clinical and non-clinical settings. SDA technology aligns well with this trend due to its ability to provide fast and sensitive nucleic acid amplification, making it suitable for on-site testing applications. With an increasing focus on decentralized healthcare and the need for immediate results, the demand for SDA-based POCT solutions is expected to surge.
The primary driver propelling the market for Strand Displacement Amplification (SDA) is the escalating demand for accurate and rapid diagnostic solutions across various sectors, including healthcare, veterinary medicine, agriculture, and environmental monitoring. SDA offers several advantages such as high specificity, sensitivity, and robustness, making it an attractive choice for detecting nucleic acids with precision. As the need for timely diagnosis and surveillance of infectious diseases, genetic disorders, and environmental contaminants intensifies, the demand for SDA technology-driven assays and kits continues to grow. Additionally, the ongoing COVID-19 pandemic has underscored the importance of reliable molecular diagnostic techniques, further fueling the adoption of SDA-based assays for infectious disease detection.
A compelling opportunity within the market for Strand Displacement Amplification (SDA) lies in expanding into emerging markets, particularly in regions with limited access to sophisticated diagnostic infrastructure. These markets often face challenges related to disease surveillance, early detection, and monitoring due to resource constraints and geographical barriers. By introducing cost-effective and user-friendly SDA-based diagnostic platforms tailored to the specific needs of these regions, companies can address unmet healthcare needs and tap into a vast market potential. Moreover, collaborations with local healthcare providers, government agencies, and non-profit organizations can facilitate market penetration and promote the adoption of SDA technology in resource-limited settings, thereby improving healthcare outcomes and fostering socio-economic development.
In the Strand Displacement Amplification Market, the application segment of Tuberculosis is experiencing rapid growth. Strand Displacement Amplification (SDA) technology is increasingly utilized for the detection and diagnosis of tuberculosis (TB), a bacterial infection caused by Mycobacterium tuberculosis. SDA assays offer advantages such as high sensitivity, specificity, and rapid turnaround time, making them well-suited for TB diagnosis in both high- and low-resource settings. With TB remaining a significant global health burden, particularly in regions with limited healthcare infrastructure, there is a growing demand for accurate and efficient diagnostic tools to facilitate early detection and treatment of the disease. Hospitals, diagnostic laboratories, and other healthcare facilities are the primary end-users adopting SDA technology for TB diagnosis, reflecting its importance in clinical practice. As TB control efforts intensify and the need for rapid and reliable TB diagnostics continues to grow, the market for SDA assays in TB detection is expected to continue its rapid growth trajectory. Additionally, ongoing research and development efforts focused on improving SDA assay performance and expanding its applications in TB diagnosis further contribute to market expansion in this segment.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossBi-Rad Laboratories Inc, G Biosciences, Hopax Fine Chemicals Co. Ltd, Lucigen Corp, Lucira Health Inc, New England Biolabs Inc, Nippon Genetics Co. Ltd, PCR Biosystems Ltd, Sherlock Biosciences Inc
By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Others
By End-User
Hospitals
Diagnostic laboratories
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Bi-Rad Laboratories Inc
G Biosciences
Hopax Fine Chemicals Co. Ltd
Lucigen Corp
Lucira Health Inc
New England Biolabs Inc
Nippon Genetics Co. Ltd
PCR Biosystems Ltd
Sherlock Biosciences Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Strand Displacement Amplification Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Strand Displacement Amplification Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Strand Displacement Amplification Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Strand Displacement Amplification Market Size Outlook, $ Million, 2021 to 2030
3.2 Strand Displacement Amplification Market Outlook by Type, $ Million, 2021 to 2030
3.3 Strand Displacement Amplification Market Outlook by Product, $ Million, 2021 to 2030
3.4 Strand Displacement Amplification Market Outlook by Application, $ Million, 2021 to 2030
3.5 Strand Displacement Amplification Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Strand Displacement Amplification Industry
4.2 Key Market Trends in Strand Displacement Amplification Industry
4.3 Potential Opportunities in Strand Displacement Amplification Industry
4.4 Key Challenges in Strand Displacement Amplification Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Strand Displacement Amplification Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Strand Displacement Amplification Market Outlook by Segments
7.1 Strand Displacement Amplification Market Outlook by Segments, $ Million, 2021- 2030
By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Others
By End-User
Hospitals
Diagnostic laboratories
Others
8 North America Strand Displacement Amplification Market Analysis and Outlook To 2030
8.1 Introduction to North America Strand Displacement Amplification Markets in 2024
8.2 North America Strand Displacement Amplification Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Strand Displacement Amplification Market size Outlook by Segments, 2021-2030
By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Others
By End-User
Hospitals
Diagnostic laboratories
Others
9 Europe Strand Displacement Amplification Market Analysis and Outlook To 2030
9.1 Introduction to Europe Strand Displacement Amplification Markets in 2024
9.2 Europe Strand Displacement Amplification Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Strand Displacement Amplification Market Size Outlook by Segments, 2021-2030
By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Others
By End-User
Hospitals
Diagnostic laboratories
Others
10 Asia Pacific Strand Displacement Amplification Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Strand Displacement Amplification Markets in 2024
10.2 Asia Pacific Strand Displacement Amplification Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Strand Displacement Amplification Market size Outlook by Segments, 2021-2030
By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Others
By End-User
Hospitals
Diagnostic laboratories
Others
11 South America Strand Displacement Amplification Market Analysis and Outlook To 2030
11.1 Introduction to South America Strand Displacement Amplification Markets in 2024
11.2 South America Strand Displacement Amplification Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Strand Displacement Amplification Market size Outlook by Segments, 2021-2030
By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Others
By End-User
Hospitals
Diagnostic laboratories
Others
12 Middle East and Africa Strand Displacement Amplification Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Strand Displacement Amplification Markets in 2024
12.2 Middle East and Africa Strand Displacement Amplification Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Strand Displacement Amplification Market size Outlook by Segments, 2021-2030
By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Others
By End-User
Hospitals
Diagnostic laboratories
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Bi-Rad Laboratories Inc
G Biosciences
Hopax Fine Chemicals Co. Ltd
Lucigen Corp
Lucira Health Inc
New England Biolabs Inc
Nippon Genetics Co. Ltd
PCR Biosystems Ltd
Sherlock Biosciences Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Application
Tuberculosis
Hepatitis
Malaria
Influenza
Cancer
Others
By End-User
Hospitals
Diagnostic laboratories
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Strand Displacement Amplification Market is one of the lucrative growth markets, poised to register a 5.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Bi-Rad Laboratories Inc, G Biosciences, Hopax Fine Chemicals Co. Ltd, Lucigen Corp, Lucira Health Inc, New England Biolabs Inc, Nippon Genetics Co. Ltd, PCR Biosystems Ltd, Sherlock Biosciences Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume